Product Description
Gefticip 250 Geftinib Tablets provide a classic and meritorious option for targeted cancer therapy at an affordable price. Supplied by Cipla Ltd., each strip holds 10 film-coated, brown-colored tablets marked for easy identification. Designed as a supreme antineoplastic agent, this prescription medicine features Gefitinib 250 mg in each tablet, validated for oral administration in Non-Small Cell Lung Cancer (NSCLC). Buy online and redeem trusted quality, ensuring efficacy and safety. Store below 30C, protected from light and moisture, with a shelf life of 24 months. Gefticip offers advanced EGFR inhibition for optimal cancer management.
Targeted Oral Therapy for NSCLC
Gefticip 250 Geftinib Tablets are specifically indicated for the management of Non-Small Cell Lung Cancer (NSCLC). With its supreme targeted EGFR inhibitor feature, this classic oral formulation delivers consistent and meritorious results. Suitable for cancer therapy, each tablet is manufactured with high-quality materials and administered under professional supervision. Its application in oncology settings supports effective patient outcomes and streamlined care.
Sample Policy and Premium Packaging
Gefticip 250 Geftinib Tablets are available at the lowest price and come with premium maroon and white strip packaging. Marketed as an export-quality product, each strip contains clear markings for identification. The offer includes sample policies for clinical trials and certifications that guarantee compliance and reliability. Buyers benefit from professional packaging details, making this product ideal for suppliers, traders, and exporters across India.
FAQ's of Gefticip 250 Geftinib Tablets:
Q: How should Gefticip 250 Geftinib Tablets be administered for NSCLC treatment?
A: Gefticip 250 Geftinib Tablets are administered orally, following the dosage instructions and prescription provided by a qualified oncologist.
Q: What is the primary usage of Gefticip 250 Geftinib Tablets?
A: The primary usage of Gefticip 250 is as an antineoplastic agent for the targeted treatment of Non-Small Cell Lung Cancer (NSCLC), leveraging its EGFR inhibitor properties.
Q: When is it appropriate to redeem Gefticip 250 Geftinib Tablets?
A: Gefticip 250 should only be redeemed and used after obtaining a prescription from a certified oncologist, in accordance with cancer treatment protocols.
Q: Where can I buy Gefticip 250 Geftinib Tablets online?
A: Gefticip 250 Geftinib Tablets can be purchased online through authorized suppliers, traders, and exporter platforms based in India, ensuring prescription compliance.
Q: What are the recommended storage instructions for Gefticip 250 tablets?
A: Gefticip 250 tablets should be stored below 30C, protected from light and moisture, and kept out of reach of children for optimal preservation and safety.
Q: What is the benefit of choosing Gefticip 250 Geftinib Tablets for cancer therapy?
A: Gefticip 250 provides targeted inhibition of EGFR pathways, promoting effective control of NSCLC growth with proven safety and reliability from Cipla Ltd.